Smart Inhalers Market Overview:
In a consumerist world, consumers depend more and more on devices and after smartphone, smart cards, smart TV, smart watch, smart pads, smart boards, smart sensors and air conditioners, the world has recently witnessed an innovation called smart inhalers which is boon for people suffering from respiratory diseases like asthma. Due to its benefits like aided consultations from clinicians to patients, better asthma control, improved quality of life, ease of monitoring and tracking inhaler usage and informed decision making for clinicians, the market of smart inhalers is rising rapidly. Due to the scope of market growth, smart inhalers industry is witnessing huge innovations regarding asthma treatment and pediatric sciences. For the treatment of respiratory diseases, increasing technological advancements and the need for integrated cloud-based technologies are the key factors that are contributing to the market growth. Cloud-based solutions are being emphasized to simplify chronic respiratory disease management. These solutions also connect patients and caregivers through real-time tools and remote monitoring. Clinical approvals and growing acquisitions for various competitive products by the major players also highlight the growth of the global smart inhalers market.
Market Research Future (MRFR) has published a research report about the global smart inhalers market. According to this report, the market is expected to rise by 42.8?GR (Compound Annual Growth Rate) growth during the forecast period (2016 – 2022). Approximate growth figure by 2022 is estimated to be the US $1636.1 mn. As per statistics, dry powder inhalers hold the largest share of the market. This report segments the global smart inhalers market into types, application, end users, and region. Type-based segmentation of the market covers dry powder inhaler and metered dose inhaler. By application, the market has been segmented into asthma, chronic obstructive pulmonary disease (COPD), and others. The end-user market is segmented into by the type which comprises of dry powder inhaler, and metered dose inhaler. By application, the market is segmented into Asthma, COPD, and others. By the end user, the market is segmented into hospitals & clinics, respiratory care center, and others.
Regional segmentation of global smart inhalers market comprises of North America, Europe, Asia Pacific and rest of the world (RoW). Among all regional markets, North America is the largest market with United States of America (USA) holding the lion’s share in it. In our report, there is anticipation about the market for Smart Inhalers in North America to reach US $ 888.4 mn by 2023. The second largest regional market in Europe that was estimated to be worth the US $ 57.4 mn in 2016. The biggest market in Europe lies in developed countries in Europe. Some major players of global smart inhalers market are based in the United Kingdom (UK) and the Netherlands. During the forecast period, Asia Pacific market is estimated to grow at 55.3?GR where biggest markets can be Australia, China, and New Zealand. The market in the rest of the world is expected to rise after 2019 where countries of the Middle East are being projected as the primary market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2117
Major key Players:
The key players of global smart inhalers market include Adherium (New Zealand), Amiko Digital Health (UK), AstraZeneca (UK), Cohero Health (USA), GlaxoSmithKline (UK), Gecko Health Innovations Inc. (The Netherlands), Inspiro Medical (USA), and Propeller Health (USA).
Smart Inhalers Market Segmentation:
By type, the Global Smart Inhalers Market has been bifurcated into dry powder inhaler and metered dose inhaler.
Based on application, the smart inhalers market has been segmented into Asthma, COPD, and others.
On the basis of end user, the global smart market is segmented into respiratory care center, hospitals & clinics, and others.
Smart Inhalers Market Geographical Analysis:
The regional analysis of the smart inhalers comprises regions such as North America, Middle East, Europe, Africa, APAC and rest of the world. Globally, the North American region is the major market for smart inhalers which is predicted to touch $888.4 million in revenues approximately by 2023. The European region was the second biggest market in 2016 which is worth $57.4 million. Additionally, the Asia Pacific market is anticipated to be the most rapidly growing market and is likely to develop at a CAGR of 55.3 percent during the forecast period from 2016 to 2022. The smart inhalers market in the rest of world is anticipated to surge after 2019.
Access full report @ https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117
Smart inhaler company Adherium has received 510, 000 clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler. This device is called the SmartTouch for Symbicort.
Amiko Digital Health has landed Conformité Européene (CE) Mark approval for its Respiro sensors. The platforms that will use Respiro are Chiesi’s Nexthaler, GlaxoSmithKline’s Ellipta inhalers, and Teva’s Spiromax. The Respiro system can record the usage of an inhaler at the time of access. It can pass that information in real-time to a patient’s phone and onto its portal. Patients, doctors, and researchers can access and analyze the information to gain insights into the results and impact of therapy, along with possibilities to improve a regimen.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.